Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy women between the ages of 20 and 45~* Have used effective contraception for 2 weeks prior to starting in the study~* Does not have a temperature within 24 hours before the first injection~Exclusion Criteria:~* Prior history of genital warts~* More than 4 lifetime sexual partners~* Have undergone hysterectomy~* Have active cervical disease or history of cervical disease

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- qHPV (Type: EXPERIMENTAL): Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine administered by intramuscular injection on Day 1, Month 2, and Month 6
- Placebo (Type: PLACEBO_COMPARATOR): Placebo administered by intramuscular injection on Day 1, Month 2, and Month 6

Based on this trial design, predict the completion outcome and termination type (if applicable).